EUVIMEDAtrasti EUVIMED
Mixed-Methods-StudieOpen access

Business Venturing in Regulated Markets—Taxonomy and Archetypes of Digital Health Business Models in the European Union: Mixed Methods Descriptive and Exploratory Study

Business Venturing in regulierten Märkten – Taxonomie und Archetypen digitaler Health-Business-Modelle in der Europäischen Union: gemischte deskriptive und explorative Studie

Sascha Noel Weimar iD, Rahel Sophie Martjan iD, Orestis Terzidis iD

Journal of Medical Internet Research · 2025-01-09 · 27 · e65725

DOI: 10.2196/65725 ↗

Auf einen Blick

Die Studie entwickelte eine Taxonomie für DHT-Business-Modelle in der EU und identifizierte 6 Archetypen. Grundlage waren Literatur, 169 reale Modelle und 13 Experteninterviews.

Fragestellung

Welche Kernelemente und Konfigurationen von Business-Modellen für DHTs gibt es in der Europäischen Union?

Methode

2 Phasen: Taxonomie auf Basis systematischer Literaturübersicht, Analyse von 169 europäischen Business-Modellen und 13 Experteninterviews; danach 2-stufige Clusteranalyse.

Ergebnisse

11 zentrale Dimensionen in 4 Meta-Dimensionen. Identifiziert wurden 6 Archetypen: A1 bis A6, darunter Administration/Kommunikation, digitale Therapeutika, Diagnostik/Therapie und Wellness.

Schlussfolgerung der Autor:innen

Die Autor:innen heben die zentralen Elemente von DHT-Business-Modellen hervor, mit starkem Einfluss von Medizinprodukte-Regulierung und Erlösmodellen. Genannt werden 3 Treiber der Innovation.

Kernaussagen

  • Taxonomie mit 11 Dimensionen und 4 Meta-Dimensionen
  • 6 Archetypen von DHT-Business-Modellen identifiziert
  • Regulierung, Erstattung und KI prägen die Modelle

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Mixed-Methods-Studie in Journal of Medical Internet Research, published online on 2025-01-09. Written by Sascha Noel Weimar and 2 co-authors. Institution: Institute for Entrepreneurship, Technology Management and Innovation (EnTechnon), Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany. Major MEDLINE topics: European Union, Commerce. Cited 6 times so far (Crossref); 83 references. The full text is freely available in PubMed Central.

Auf einen BlickSantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

Digital health technology (DHT) has the potential to revolutionize the health care industry by reducing costs and improving the quality of care in a sector that faces significant challenges. However, the health care industry is complex, involving numerous stakeholders, and subject to extensive regulation. Within the European Union, medical device regulations impose stringent requirements on various ventures. Concurrently, new reimbursement pathways are also being developed for DHTs. In this dynamic context, establishing a sustainable and innovative business model around DHTs is fundamental for their successful commercialization. However, there is a notable lack of structured understanding regarding the overarching business models within the digital health sector.

Objective

This study aims to address this gap and identify key elements and configurations of business models for DHTs in the European Union, thereby establishing a structured understanding of the archetypal business models in use.

Methods

The study was conducted in 2 phases. First, a business model taxonomy for DHTs was developed based on a systematic literature review, the analysis of 169 European real-world business models, and qualitative evaluation through 13 expert interviews. Subsequently, a 2-step clustering analysis was conducted on the 169 DHT business models to identify distinct business model archetypes.

Results

The developed taxonomy of DHT business models revealed 11 central dimensions organized into 4 meta-dimensions. Each dimension comprises 2 to 9 characteristics capturing relevant aspects of DHT business models. In addition, 6 archetypes of DHT business models were identified: administration and communication supporter (A1), insurer-to-consumer digital therapeutics and care (A2), diagnostic and treatment enabler (A3), professional monitoring platforms (A4), clinical research and solution accelerators (A5), and direct-to-consumer wellness and lifestyle (A6).

Conclusions

The findings highlight the critical elements constituting business models in the DHT domain, emphasizing the substantial impact of medical device regulations and revenue models, which often involve reimbursement from stakeholders such as health insurers. Three drivers contributing to DHT business model innovation were identified: direct targeting of patients and private individuals, use of artificial intelligence as an enabler, and development of DHT-specific reimbursement pathways. The study also uncovered surprising business model patterns, including shifts between regulated medical devices and unregulated research applications, as well as wellness and lifestyle solutions. This research enriches the understanding of business models in digital health, offering valuable insights for researchers and digital health entrepreneurs.

Subjects

MeSH terms (MEDLINE)

European UnionCommerceHumansDigital TechnologyDelivery of Health CareDigital Health

Author keywords

AIEuropean Unionarchetypesartificial intelligencebusiness modelclassificationdigital healthmedical device regulationsmobile healthmobile phonetelemedicine

Authors and institutions

  • Institute for Entrepreneurship, Technology Management and Innovation (EnTechnon), Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.

ORCID profiles: Sascha Noel Weimar, Rahel Sophie Martjan, Orestis Terzidis

Cite

APA

Weimar, S. N., Martjan, R. S., & Terzidis, O. (2025). Business Venturing in Regulated Markets—Taxonomy and Archetypes of Digital Health Business Models in the European Union: Mixed Methods Descriptive and Exploratory Study. Journal of Medical Internet Research, 27, e65725. https://doi.org/10.2196/65725

Vancouver

Weimar SN, Martjan RS, Terzidis O. Business Venturing in Regulated Markets—Taxonomy and Archetypes of Digital Health Business Models in the European Union: Mixed Methods Descriptive and Exploratory Study. Journal of Medical Internet Research. 2025;27:e65725. doi:10.2196/65725

BibTeX
@article{Weimar2025,
  author = {Weimar, Sascha Noel and Martjan, Rahel Sophie and Terzidis, Orestis},
  title = {Business Venturing in Regulated Markets—Taxonomy and Archetypes of Digital Health Business Models in the European Union: Mixed Methods Descriptive and Exploratory Study},
  journal = {Journal of Medical Internet Research},
  year = {2025},
  volume = {27},
  pages = {e65725},
  doi = {10.2196/65725}
}
Start for free →